HomeInsightsShare Holding

Gland Pharma Ltd Share Holding Pattern

Gland Pharma Ltd Share Holding Pattern

stocks purchased

₹ 6.3 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

34.5 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Promoters Holdings Over Time

Key Highlights

  • FIIs/FPIs increased their stake in the company by 3.29% from March 2024 to June 2024. Mutual funds increased their stake in the company by 7.52% from March 2024 to June 2024.
  • Promoters decreased their stake in the company by 6.02% from March 2024 to June 2024.

Latest Shareholding

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20241825.5
24 Dec 20241779.9
23 Dec 20241766.05
20 Dec 20241769.75
19 Dec 20241775.8
18 Dec 20241763.9
17 Dec 20241751.05
16 Dec 20241731.3
13 Dec 20241748.2
12 Dec 20241778.6

Gland Pharma Ltd News Hub

News

Gland Pharma subsidiary receives 10 observations from French drug regulator ANSM

In a regulatory filing made yesterday, the company stated that the Agence nationale de s'c...

Read more

26 Dec 2024 09:36

News

Gland Pharma rises on USFDA nod for vitamin-K deficiency drug

The product is bioequivalent and therapeutically equivalent to the reference listed drug (...

Read more

12 Dec 2024 10:06

News

Gland Pharma receives USFDA approval for Phytonadione Injectable Emulsion

Gland Pharma has received approval from the United States Food and Drug Administration (US...

Read more

11 Dec 2024 18:20

News

Gland Pharma rises on USFDA nod for ophthalmic solution

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Dec 2024 11:05

News

Gland Pharma Ltd spurts 1.67%, rises for third straight session

Gland Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1809....

Read more

03 Dec 2024 13:06

News

Gland Pharma soars as Q2 PAT rises 9% QoQ to Rs 282 cr

On a consolidated basis, the firm's net profit declined 15.74% to Rs 163.53 crore despite ...

Read more

05 Nov 2024 10:42

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Oct 2022

PPT

July 2022

TranscriptPPT

Sep 2021

PPT

July 2021

TranscriptPPT

Feb 2021

Transcript

FAQs for EPS of Gland Pharma Ltd

On what factors does the shareholding pattern of Gland Pharma Ltd change frequently?

The shareholding pattern of Gland Pharma Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Gland Pharma Ltd's shareholding pattern updated?

The Gland Pharma Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Gland Pharma Ltd?

Categories included in the shareholding pattern of Gland Pharma Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Gland Pharma Ltd important for investors?

The shareholding pattern of Gland Pharma Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Gland Pharma Ltd?

The latest shareholding pattern of Gland Pharma Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions